Dongwha Pharm has acquired a 51% stake in Trung Son Pharma for USD 30 million, aiming to strengthen its presence in Vietnam's growing healthcare sector.

Target Information

This month, the M&A landscape in Vietnam is witnessing a notable resurgence, with a total transaction value of approximately USD 0.5 billion. The majority of this activity has been concentrated in several key sectors, particularly Technology, Healthcare, and Energy and Utilities. Highlighting this trend, VNG Corporation, a leading internet company in Vietnam, is in the process of raising USD 150 million through a U.S. stock market listing, with plans for a trading debut slated for either late September or October.

In the Healthcare sector, Dongwha Pharm is making a strategic move by acquiring a 51% stake in Trung Son Pharma for USD 30 million. Trung Son operates more than 140 pharmacies, chiefly located in southern Vietnam, with significant market presence in Can Tho City. This acquisition aligns with the increasing demand for both prescription and non-prescription medications in the region.

Industry Overview

Vietnam's economy is experiencing robust growth, making it an attractive destination for foreign investments, particularly in the M&A space. The Technology sector has garnered particular attention due to the rapid digi